| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
202,700,000 as of 6/30 |
| Market
Cap: |
20.37(B) |
| Last
Volume: |
690,216 |
Avg
Vol: |
1,249,206 |
| 52
Week Range: |
$72.18 - $101.77 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 92 |
| Guru Rank Value : 7.4 |
| Guru Occurances : 4 |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. Co.'s operations consist of three business segments: BD Medical, which produces an array of medical devices that are used in a range of healthcare settings; BD Diagnostics, which provides products for the collection and transport of diagnostics specimens, as well as instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Biosciences, which produces research and clinical tools that facilitate the study of cells, and the components of cells.
|
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
65,812 |
139,974 |
176,181 |
271,443 |
| Total Sell Value |
$6,162,786 |
$12,528,278 |
$15,254,868 |
$22,600,903 |
| Total People Sold |
4 |
10 |
12 |
14 |
| Total Sell Transactions |
5 |
16 |
20 |
29 |
| End Date |
2013-02-17 |
2012-11-16 |
2012-05-18 |
2011-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Boles Donna M |
Senior VP - Human Resources |
|
2013-05-17 |
4 |
D |
$101.38 |
$591,654 |
D/D |
(5,836) |
17,022 |
|
- |
|
Boles Donna M |
Senior VP - Human Resources |
|
2013-05-17 |
4 |
OE |
$71.72 |
$591,762 |
D/D |
8,251 |
22,858 |
|
- |
|
Boles Donna M |
Senior VP - Human Resources |
|
2013-05-17 |
4 |
S |
$101.38 |
$244,833 |
D/D |
(2,415) |
14,607 |
|
- |
|
Cohen Gary M |
Executive Vice President |
|
2013-05-13 |
4 |
S |
$100.22 |
$877,226 |
D/D |
(8,753) |
66,577 |
|
-0% |
|
Cohen Gary M |
Executive Vice President |
|
2013-05-13 |
4 |
D |
$100.22 |
$1,262,772 |
D/D |
(12,600) |
75,330 |
|
- |
|
Cohen Gary M |
Executive Vice President |
|
2013-05-13 |
4 |
OE |
$59.16 |
$1,263,243 |
D/D |
21,353 |
87,930 |
|
- |
|
Sherman Jeffrey S |
Sr. VP and General Counsel |
|
2013-05-07 |
4 |
D |
$97.42 |
$888,276 |
D/D |
(9,118) |
31,075 |
|
- |
|
Sherman Jeffrey S |
Sr. VP and General Counsel |
|
2013-05-07 |
4 |
OE |
$59.16 |
$888,406 |
D/D |
15,017 |
40,193 |
|
- |
|
Sherman Jeffrey S |
Sr. VP and General Counsel |
|
2013-05-07 |
4 |
S |
$97.42 |
$574,681 |
D/D |
(5,899) |
25,176 |
|
-3% |
|
Cohen Gary M |
Executive Vice President |
|
2013-05-03 |
4 |
S |
$96.74 |
$2,242,226 |
D/D |
(23,177) |
66,577 |
|
-3% |
|
Cohen Gary M |
Executive Vice President |
|
2013-05-03 |
4 |
OE |
$54.41 |
$1,261,061 |
D/D |
23,177 |
89,754 |
|
- |
|
Lim James C |
Senior Vice President |
|
2013-03-15 |
4 |
OE |
$59.16 |
$407,654 |
D/D |
6,404 |
10,265 |
|
- |
|
Lim James C |
Senior Vice President |
|
2013-03-15 |
4 |
D |
$92.15 |
$407,395 |
D/D |
(4,421) |
7,551 |
|
- |
|
Lim James C |
Senior Vice President |
|
2013-03-15 |
4 |
S |
$92.15 |
$182,733 |
D/D |
(1,983) |
6,262 |
|
-9% |
|
Becton Henry P Jr |
Director |
|
2013-03-11 |
4 |
OE |
$84.04 |
$151,440 |
I/I |
1,802 |
92,658 |
|
- |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2013-02-20 |
4 |
S |
$87.92 |
$2,285,920 |
D/D |
(26,000) |
108,724 |
|
-15% |
|
Forlenza Vincent A |
Chairman, CEO and President |
|
2013-02-20 |
4 |
OE |
$38.78 |
$1,008,280 |
D/D |
26,000 |
134,724 |
|
- |
|
Sichak Stephen |
Senior Vice President |
|
2013-02-15 |
4 |
OE |
$59.16 |
$527,471 |
D/D |
8,916 |
16,271 |
|
- |
|
Sichak Stephen |
Senior Vice President |
|
2013-02-15 |
4 |
D |
$88.34 |
$528,185 |
D/D |
(5,979) |
10,292 |
|
- |
|
Sichak Stephen |
Senior Vice President |
|
2013-02-15 |
4 |
S |
$88.34 |
$259,455 |
D/D |
(2,937) |
7,355 |
|
-14% |
|
Orr James F |
Director |
|
2013-02-11 |
4 |
S |
$88.28 |
$391,610 |
D/D |
(4,436) |
19,608 |
|
-14% |
|
Orr James F |
Director |
|
2013-02-11 |
4 |
OE |
$49.05 |
$235,211 |
D/D |
4,436 |
24,044 |
|
- |
|
Scott Bertram L |
Director |
|
2013-02-08 |
4 |
D |
$88.36 |
$89,244 |
D/D |
(1,010) |
20,379 |
|
- |
|
Scott Bertram L |
Director |
|
2013-02-08 |
4 |
OE |
$32.07 |
$89,187 |
D/D |
2,781 |
21,389 |
|
- |
|
Sherman Jeffrey S |
Sr. VP and General Counsel |
|
2013-02-07 |
4 |
S |
$87.30 |
$1,423,077 |
D/D |
(16,301) |
25,176 |
|
-14% |
|
896 Records found
|
|
Page 1 of 36 |
|
|